Double-unit UCBT best for acute leukaemia?

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.646, 2012-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytarabine/etoposide/ibritumomab tiuxetan Y-90: Treatment-related acute myeloid leukaemia?: case report

Reactions Weekly, Vol. 1, Iss. 1295, 2010-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Corticosteroids/mycophenolate mofetil/tacrolimus: Atypical acute leukaemia?: case report

Reactions Weekly, Vol. 1, Iss. 1290, 2010-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

New therapies for mature T-cell leukaemia?

Inpharma, Vol. 1, Iss. 1315, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Liposomal daunorubicin + cytarabarine valid for leukaemia?

Inpharma, Vol. 1, Iss. 1413, 2003-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Cost Analyses Of Adjunct Colony Stimulating Factors For Older Patients With Acute Myeloid Leukaemia: Can they Improve Clinical Decision Making?

By Bennett C.L. Schumock G.T.

Drugs & Aging, Vol. 20, Iss. 7, 2003-01 ,pp. : 479-483

Adis International

Access to resources Recommend Favorite